Exhibiting at Thaifex - Anuga Asia 2025

Chuncheon Bioindustry Foundation (CBF), headquartered in Chuncheon, Republic of Korea, is a leading public-sector biotech incubator and research foundation supporting the development of life sciences and biomedical innovation. With a mission to foster high-tech biotechnology ventures, the foundation plays a pivotal role in facilitating clinical research, biopharmaceutical production, and the commercialization of health functional foods in Korea and beyond.

Company Overview

Established in 2003 by the city of Chuncheon and regional authorities, Chuncheon Bioindustry Foundation serves as a cornerstone of the Chuncheon Bio Cluster. The foundation is committed to nurturing bio-venture enterprises by offering infrastructure, R&D collaboration, regulatory support, and market entry assistance. Its state-of-the-art GMP-certified facilities and collaborative academic-industry network have positioned it as a catalyst in South Korea’s biotechnology sector.

Product and Service Offerings

CBF supports the biotech ecosystem through its own research initiatives and collaborative ventures, offering:

• Biopharmaceutical Development:

  • Biosimilar Protein Therapeutics: Support in formulation, scale-up, and preclinical testing.
  • Antibody Drugs: Monoclonal antibody research and development for oncology and autoimmune indications.

• Health Functional Foods:

  • Bio Ginseng Drink: A functional beverage based on Korean red ginseng and fermentation technology, targeting immunity and vitality.

• Research & Clinical Services:

  • Preclinical & Clinical Trial Design
  • Bioanalytics & Toxicology Assessment
  • Antibody Screening & Characterization

• Startup Incubation Services:

  • Bio-Venture Startup Mentoring
  • Shared Laboratory Access
  • GMP Production Support
  • Technology Transfer Facilitation

The foundation not only produces health-focused solutions but also empowers biotech SMEs to scale safely and compliantly within global frameworks.

Core Specialization and USP

CBF’s unique positioning is defined by:

• GMP Facility Infrastructure: Fully equipped small-scale production facilities for clinical trial materials and pilot runs.
• Public-Private Research Collaboration: Works in partnership with universities, government, and the private sector.
• K-Bio Certification Support: Assists Korean bio companies in acquiring required regulatory approvals and certifications for export.
• Biotech Ecosystem Building: Anchors the Chuncheon Bio Cluster, comprising over 60 biotech companies and 15+ institutional research centers.

These strengths make CBF a strategic enabler for biotech innovation from bench to market.

Financials and Export Shipments

As a government-funded foundation, CBF does not operate as a revenue-driven entity. However, its impact is measured through:

• Support for over 130 bio-venture companies since inception
• More than 80 completed clinical and preclinical projects
• Facilitated exports of biotech products to over 10 countries, including the U.S., Japan, and EU member states, through partner companies
• Annual budget allocations exceeding KRW 5 billion, focused on R&D, equipment upgrades, and startup acceleration

These indicators underscore its financial and infrastructural significance in the Korean biotech sector.

Target Market

CBF supports stakeholders across the life science value chain:

• Biotech Startups seeking pilot-scale production and regulatory support
• Pharmaceutical Companies in need of antibody drug R&D partnerships
• Universities and Academic Research Labs pursuing translational research
• Health Food Innovators exploring fermentation-based functional ingredients

The foundation's flexible infrastructure supports both early-stage discovery and near-market commercialization.

Capabilities

• Pilot GMP Manufacturing Suites
• Antibody Screening Platforms
• Bio-Incubation Facilities with BSL-2/3 Labs
• Analytical and Biochemical Instrumentation including HPLC, GC-MS, ELISA, FACS

CBF also manages a comprehensive startup assistance program including IP consulting, market validation, and export certification guidance.

Certifications and Compliance

The foundation adheres to strict national and international quality and safety protocols:

• KFDA (Korea Food and Drug Administration) GMP Certified
• ISO 9001: Quality Management Systems
• Compliance with OECD GLP Guidelines for preclinical research
• Facility approvals for bio-safety levels BSL-2 and BSL-3 laboratories

These credentials make CBF a trusted R&D partner for government contracts and cross-border clinical collaborations.

Customer Testimonials

Though formal testimonials are limited, university-affiliated startups and incubated companies often cite:

• Seamless access to top-tier lab space and research support
• Accelerated R&D and prototyping through on-site GMP pilot lines
• Assistance in securing regulatory approvals and market entry pathways

Case studies of CBF-supported companies indicate improved time-to-market and expanded international reach.

Major Achievements

• Anchor institution for Chuncheon Bio Cluster, now housing over 60 biotech firms
• Developed and launched Bio Ginseng Drink, now available across health product distributors in Korea
• Successful facilitation of international clinical trials for Korean-developed antibody therapeutics
• Organized Bio Korea and Chuncheon Bio Expo events to promote innovation and investment
• Key partner in national precision medicine initiatives under Korea’s Ministry of Health and Welfare

Chuncheon Bioindustry Foundation continues to serve as a critical infrastructure pillar for South Korea’s ambitions in biotechnology, pharmaceutical innovation, and functional food science, driving research from lab to life-saving application.